SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) (“bluebird bio” or “bluebird”) today announced the U.S. Food and Drug Administration ...
Blue Bird’s growth is expected to accelerate with school bus sales expected to return to pre-pandemic levels in CY 2026, indicating an acceleration in the current replacement cycle. State-level laws ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback